Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Wealthcare Advisory Partners LLC Reduces Holdings in MetLife, Inc.

Wealthcare Advisory Partners Llc, a prominent institutional investor, has announced a reduction in its holdings of MetLife, Inc. (NYSE:MET) by 16.8% during the second quarter of this year. According to the company’s most recent 13F filing with the Securities and Exchange Commission (SEC), Wealthcare Advisory Partners LLC now owns 11,053 shares of MetLife’s stock, having sold 2,228 shares during the reporting period. The total value of their holdings in MetLife amounts to $625,000 as of the latest SEC filing.

MetLife is a leading financial services provider known for its expertise in insurance and asset management offerings. This news of decreased holdings by Wealthcare Advisory Partners LLC may be indicative of a shift in market sentiment towards the company. However, it is important to note that individual investors often make adjustments to their portfolios based on various factors such as market conditions and investment strategies.

In addition to the reduction in holdings, MetLife recently declared a quarterly dividend which was paid on Thursday, September 14th. Shareholders who held MET stocks as of Tuesday, August 8th were eligible for this dividend payout. Each shareholder received $0.52 per share owned. The ex-dividend date for this payment fell on Monday, August 7th.

Currently, MetLife’s dividend payout ratio stands at approximately 80.93%. This ratio reflects the proportion of earnings that the company distributes to its shareholders as dividends. With an annualized dividend amounting to $2.08 per share and a yield of 3.31%, MetLife remains committed to providing consistent returns to its shareholders.

It is worth noting that financial performance and dividend policies can vary over time due to numerous factors such as economic conditions and business strategies employed by companies like MetLife. Market participants should analyze relevant information available at any given point in time before making investment decisions or evaluating ongoing developments within the financial services sector.

In conclusion, Wealthcare Advisory Partners LLC has decreased its holdings in MetLife, Inc. during the second quarter of this year. This development could potentially indicate a change in investor sentiment towards the company. Additionally, MetLife recently paid out its quarterly dividend, reinforcing its commitment to providing returns to shareholders. Investors and market participants should diligently monitor the ever-evolving landscape of the financial services industry for valuable insights and considerations before taking any investment actions or making judgments based solely on past information.

Allscripts Healthcare Solutions, Inc.

MDRX

Buy

Updated on: 29/09/2023

Financial Health

Healthy


Debt to equity ratio: Neutral

Price to earnings ratio: Strong Buy

Price to book ratio: Strong Buy

DCF: Strong Buy

ROE: Neutral

Show more

Price Target

Current $13.38

Concensus $19.25


Low $18.50

Median $19.25

High $20.00

Show more

Social Sentiments

4:00 PM (UTC)

Date:28 September, 2023
Show more

Analyst Ratings

Analyst / firm Rating
Piper Sandler Buy
J.P. Morgan Buy
Piper Sandler Buy
Piper Sandler Buy
Show more

Increased Institutional Investor Attention Boosts Outlook for MetLife


September 28, 2023 – MetLife (NYSE: MET), a leading financial services provider, has recently received increased attention from institutional investors. According to reports, the Illinois Municipal Retirement Fund has boosted its stake in MetLife by 41.6%, now owning over 116,658 shares valued at $6,759,000. Additionally, HB Wealth Management LLC has increased its position by 4.6%, owning 6,905 shares worth $390,000. Asset Dedication LLC also showed confidence in the company by boosting its position by 10.7%, now owning 11,543 shares valued at $666,000.

The interest from these institutional investors reflects a growing trend among industry experts who have shared their positive views on MetLife’s future prospects in recent research reports. Citigroup raised their price target from $76.00 to $81.00 and gave the company a “buy” rating. Similarly, Wells Fargo & Company adjusted their price target from $82.00 to $83.00 and rated the stock as “overweight.” Argus upped their price objective to $77.00 with a “buy” rating while Jefferies Financial Group upgraded MetLife’s rating from “hold” to “buy,” with a new price objective of $72.00.

Morgan Stanley joined these favorable perspectives by raising their price objective to $79.00 and providing an “overweight” rating on MetLife stock. Overall, Bloomberg.com data indicates that MetLife has an average rating of “Moderate Buy” and an average target price of $76.40.

As of market open on Thursday, September 28th, shares of MetLife were priced at $62.80. The company holds a market capitalization of approximately $47.23 billion and maintains a debt-to-equity ratio of 0.50.

MetLife’s most recent quarterly earnings report, released on August 2nd, revealed that the financial services provider had exceeded expectations. The company reported earnings per share (EPS) of $1.94 for the quarter, surpassing the consensus estimate of $1.85 by $0.09. MetLife’s revenue for the quarter was $16.62 billion, slightly lower than analyst estimates of $16.91 billion.

Despite the positive results, MetLife continues to face challenges within the ever-evolving financial landscape. However, industry analysts remain optimistic about its future performance, with sell-side analysts predicting an estimated 7.78 earnings per share for the current fiscal year.

In conclusion, institutional investors have been showing increased interest in MetLife as they make changes to their portfolios. Notably, Illinois Municipal Retirement Fund and HB Wealth Management LLC have significantly boosted their positions in the company. Moreover, prominent equities research analysts have expressed positive sentiments towards MetLife and raised their target prices accordingly.

MetLife continues to demonstrate resilience amidst a dynamic market environment and has delivered strong quarterly earnings that have beat market expectations. These factors combine to project a promising future for MetLife and instill confidence among investors who see great potential in this leading financial services provider.

DISCLAIMER: Investments in securities involve risks including the possible loss of principal amount invested.

The post Wealthcare Advisory Partners LLC Reduces Holdings in MetLife, Inc. appeared first on Best Stocks.



This post first appeared on Best Stocks, please read the originial post: here

Share the post

Wealthcare Advisory Partners LLC Reduces Holdings in MetLife, Inc.

×

Subscribe to Best Stocks

Get updates delivered right to your inbox!

Thank you for your subscription

×